Andrew Dickinson

Andrew Dickinson is the current CFO at Gilead Sciences. Prior to this, they were a Managing Director and Global Co-Head of Healthcare Investment Banking at Lazard from August 2007 to November 2016. Andrew has also held positions as General Counsel and Vice President Corporate Development at Myogen Inc from December 2004 to April 2007, and as an Associate at Cooley LLP from May 1999 to December 2002. In 2003, Andrew co-founded Kendall, Dickinson & Koenig LLC, where they served as a partner until December 2004. Andrew has a wealth of experience in the corporate legal world, and their experience will no doubt be a valuable asset to Gilead Sciences.

Andrew Dickinson attended the University of Colorado Boulder, where they earned a Bachelor of Arts in Molecular Biology. Andrew then attended Loyola University Chicago, where they earned a Doctor of Law with Honors.

Andrew Dickinson works with Jyoti Mehra - EVP, HR, Christi Shaw - CEO, Kite, and Deborah H. Telman - EVP, Corporate Affairs & General Counsel. Andrew Dickinson reports to Daniel O’day, Chairman & CEO.